Sign Up to Receive Your Personalised Learning Resources
CONFERENCE HUB
Per Ljungman, EBMT23: Outcomes and mortality in cytomegalovirus seropositive allogeneic stem cell transplantation patients with COVID-19
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management
View
Phase 3 BASIS trial – efficacy and safety of marstacimab in severe haemophilia A or B without inhibitors: Davide Matino, ASH 2023
View
Jorge Cortes, EHA 2023: The use of quizarpenib in patients with acute myeloid leukaemia
View
Robin Foa, EBMT23: Should we transplant all patients with Philadelphia positive ALL?
View
Anna Sureda: Highlights from EBMT23!
View
Revumenib in relapsed/refractory KMT2Ar acute leukaemia – AUGMENT-101 phase 2 study: Ibrahim Aldoss, ASH 2023
View
Marina Kremyanskaya, EHA 2023: Findings of the REVIVE study of rusfertide in polycythaemia vera
View
Johan de Munter, EBMT 2023: Highlights from the Nurses Group Keynote Lecture
View
John Mascarenhas, EHA 2023: Phase II MANIFEST trial: Pelabresib combined with ruxolitinib for patients with myelofibrosis
View
Renoir phase 3 study – rituximab and lenalidomide versus rituximab for elderly patients with r/r follicular lymphoma: Umberto Vitolo, ASH 2023
View